Prioritizing candidate drug targets for diseases with complex etiologies
My research has focused on the logic of gene expression regulation, particularly in response to stress. In particular, I have utilized and integrated high-dimensional data to address complex questions about regeneration, neurodegeneration, development, and evolution. My role in the Open-AD consortium is to integrate genomic evidence in support of the prioritization and development of new therapeutic targets for the treatment of Alzheimer's disease.
Carnegie Mellon University
Adv: Dr. Veronica Hinman
University of Washington
Ph.D., Molecular and Cellular Biology
Adv: Aimee Dudley